{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:51:19Z","timestamp":1787705479000,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02527"],"award-info":[{"award-number":["22H02527"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08369"],"award-info":[{"award-number":["22K08369"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Promotion of Okayama University of Science (OUS) Research Project","award":["OUS-RP-21-1"],"award-info":[{"award-number":["OUS-RP-21-1"]}]},{"name":"The Sanyo Broadcasting Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    One feature of hypertension is a microbial imbalance with increased intestinal permeability. In this study, we examined whether an alteration in the microbiota affects blood pressure and intestinal permeability in spontaneously hypertensive rats (SHRs). We performed a 16S metagenome analysis of feces from 10- to 15-week-old SHRs using a synthetic long-read sequencing approach, and found a candidate for the microbiome treatment,\n                    <jats:italic>Ligilactobacillus murinus<\/jats:italic>\n                    (\n                    <jats:italic>L. murinus<\/jats:italic>\n                    ), that was robustly decreased. Oral administration of\n                    <jats:italic>L. murinus<\/jats:italic>\n                    to SHRs for 2\u00a0weeks significantly inhibited blood pressure elevation and improved endothelium-dependent vasodilation but did not attenuate enhanced vascular contraction in SHR mesenteric arteries. The proximal colon of SHRs exhibited increased intestinal permeability with decreased levels of the tight junction protein claudin 4, morphological changes such as decreased intestinal crypts and elevated TNF-\u03b1 levels, which was reversed by treatment with\n                    <jats:italic>L. murinus<\/jats:italic>\n                    . Consistent with these intestinal phenotypes, plasma lipopolysaccharides levels were elevated in SHR but decreased following\n                    <jats:italic>L. murinus<\/jats:italic>\n                    administration. We concluded that oral administration of\n                    <jats:italic>L. murinus<\/jats:italic>\n                    to SHRs exerts protective effects on intestinal permeability via restoration of claudin 4 expression and reversal of morphologic disorder, which may improve low-grade endotoxemia and thus reduce development of hypertension via recovery of endothelial vasodilating functions.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-42377-7","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T10:47:06Z","timestamp":1694688426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Treatment with Ligilactobacillus murinus lowers blood pressure and intestinal permeability in spontaneously hypertensive rats"],"prefix":"10.1038","volume":"13","author":[{"given":"Masashi","family":"Mukohda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyasu","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Miyamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risuke","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"42377_CR1","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala, S. M. et al. Role of the normal gut microbiota. World J. Gastroenterol. 21, 8787\u20138803. https:\/\/doi.org\/10.3748\/wjg.v21.i29.8787 (2015).","journal-title":"World J. Gastroenterol."},{"key":"42377_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fncel.2015.00392","volume":"9","author":"JR Kelly","year":"2015","unstructured":"Kelly, J. R. et al. Breaking down the barriers: The gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front. Cell Neurosci. 9, 392. https:\/\/doi.org\/10.3389\/fncel.2015.00392 (2015).","journal-title":"Front. Cell Neurosci."},{"key":"42377_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MOG.0000000000000139","volume":"31","author":"AB Shreiner","year":"2015","unstructured":"Shreiner, A. B., Kao, J. Y. & Young, V. B. The gut microbiome in health and in disease. Curr. Opin. Gastroenterol. 31, 69\u201375. https:\/\/doi.org\/10.1097\/MOG.0000000000000139 (2015).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"42377_CR4","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","volume":"388","author":"GBDRF Collaborators","year":"2016","unstructured":"Collaborators, G. B. D. R. F. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1659\u20131724. https:\/\/doi.org\/10.1016\/S0140-6736(16)31679-8 (2016).","journal-title":"Lancet"},{"key":"42377_CR5","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","volume":"65","author":"T Yang","year":"2015","unstructured":"Yang, T. et al. Gut dysbiosis is linked to hypertension. Hypertension 65, 1331\u20131340. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05315 (2015).","journal-title":"Hypertension"},{"key":"42377_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li, J. et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5, 14. https:\/\/doi.org\/10.1186\/s40168-016-0222-x (2017).","journal-title":"Microbiome"},{"key":"42377_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003698","author":"SH Karbach","year":"2016","unstructured":"Karbach, S. H. et al. Gut microbiota promote angiotensin II-induced arterial hypertension and vascular dysfunction. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.003698 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"42377_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.309006","volume":"120","author":"MM Santisteban","year":"2017","unstructured":"Santisteban, M. M. et al. Hypertension-linked pathophysiological alterations in the gut. Circ. Res. 120, 312\u2013323. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309006 (2017).","journal-title":"Circ. Res."},{"key":"42377_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091893","author":"M Niewiem","year":"2022","unstructured":"Niewiem, M. & Grzybowska-Chlebowczyk, U. Intestinal barrier permeability in allergic diseases. Nutrients https:\/\/doi.org\/10.3390\/nu14091893 (2022).","journal-title":"Nutrients"},{"key":"42377_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"SC Bischoff","year":"2014","unstructured":"Bischoff, S. C. et al. Intestinal permeability\u2014A new target for disease prevention and therapy. BMC Gastroenterol. 14, 189. https:\/\/doi.org\/10.1186\/s12876-014-0189-7 (2014).","journal-title":"BMC Gastroenterol."},{"key":"42377_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3945\/ajcn.116.131110","volume":"105","author":"A Damms-Machado","year":"2017","unstructured":"Damms-Machado, A. et al. Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction. Am. J. Clin. Nutr. 105, 127\u2013135. https:\/\/doi.org\/10.3945\/ajcn.116.131110 (2017).","journal-title":"Am. J. Clin. Nutr."},{"key":"42377_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/CIRCRESAHA.119.315743","volume":"125","author":"Y Duan","year":"2019","unstructured":"Duan, Y. et al. Bone marrow-derived cells restore functional integrity of the gut epithelial and vascular barriers in a model of diabetes and ACE2 deficiency. Circ. Res. 125, 969\u2013988. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315743 (2019).","journal-title":"Circ. Res."},{"key":"42377_CR13","doi-asserted-by":"publisher","first-page":"H1227","DOI":"10.1152\/ajpheart.00612.2020","volume":"319","author":"CV Lewis","year":"2020","unstructured":"Lewis, C. V. & Taylor, W. R. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 319, H1227\u2013H1233. https:\/\/doi.org\/10.1152\/ajpheart.00612.2020 (2020).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"42377_CR14","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.ebiom.2020.102649","volume":"52","author":"M Troseid","year":"2020","unstructured":"Troseid, M., Andersen, G. O., Broch, K. & Hov, J. R. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions. EBioMedicine 52, 102649. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102649 (2020).","journal-title":"EBioMedicine"},{"key":"42377_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40168-020-00821-0","volume":"8","author":"N Kazemian","year":"2020","unstructured":"Kazemian, N., Mahmoudi, M., Halperin, F., Wu, J. C. & Pakpour, S. Gut microbiota and cardiovascular disease: Opportunities and challenges. Microbiome 8, 36. https:\/\/doi.org\/10.1186\/s40168-020-00821-0 (2020).","journal-title":"Microbiome"},{"key":"42377_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/CIRCRESAHA.121.318065","volume":"128","author":"EG Avery","year":"2021","unstructured":"Avery, E. G. et al. The gut microbiome in hypertension: Recent advances and future perspectives. Circ. Res. 128, 934\u2013950. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318065 (2021).","journal-title":"Circ. Res."},{"key":"42377_CR17","doi-asserted-by":"publisher","first-page":"111334","DOI":"10.1016\/j.biopha.2021.111334","volume":"137","author":"A Grylls","year":"2021","unstructured":"Grylls, A., Seidler, K. & Neil, J. Link between microbiota and hypertension: Focus on LPS\/TLR4 pathway in endothelial dysfunction and vascular inflammation, and therapeutic implication of probiotics. Biomed. Pharmacother. 137, 111334. https:\/\/doi.org\/10.1016\/j.biopha.2021.111334 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"42377_CR18","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri, M. Leaky gut: Mechanisms, measurement and clinical implications in humans. Gut 68, 1516\u20131526. https:\/\/doi.org\/10.1136\/gutjnl-2019-318427 (2019).","journal-title":"Gut"},{"key":"42377_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1152\/physiolgenomics.00087.2019","volume":"52","author":"T Yang","year":"2020","unstructured":"Yang, T. et al. Transcriptomic signature of gut microbiome-contacting cells in colon of spontaneously hypertensive rats. Physiol. Genomics 52, 121\u2013132. https:\/\/doi.org\/10.1152\/physiolgenomics.00087.2019 (2020).","journal-title":"Physiol. Genomics"},{"key":"42377_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphys.2019.00231","volume":"10","author":"M Toral","year":"2019","unstructured":"Toral, M. et al. Critical role of the interaction gut microbiota\u2014Sympathetic nervous system in the regulation of blood pressure. Front. Physiol. 10, 231. https:\/\/doi.org\/10.3389\/fphys.2019.00231 (2019).","journal-title":"Front. Physiol."},{"key":"42377_CR21","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1172\/JCI12464","volume":"107","author":"C Van Itallie","year":"2001","unstructured":"Van Itallie, C., Rahner, C. & Anderson, J. M. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J. Clin. Investig. 107, 1319\u20131327. https:\/\/doi.org\/10.1172\/JCI12464 (2001).","journal-title":"J. Clin. Investig."},{"key":"42377_CR22","doi-asserted-by":"publisher","first-page":"L524","DOI":"10.1152\/ajplung.00077.2014","volume":"307","author":"H Kage","year":"2014","unstructured":"Kage, H. et al. Claudin 4 knockout mice: Normal physiological phenotype with increased susceptibility to lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 307, L524-536. https:\/\/doi.org\/10.1152\/ajplung.00077.2014 (2014).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"42377_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40813-022-00264-z","volume":"8","author":"R Saleri","year":"2022","unstructured":"Saleri, R. et al. Effects of different short-chain fatty acids (SCFA) on gene expression of proteins involved in barrier function in IPEC-J2. Porcine Health Manag. 8, 21. https:\/\/doi.org\/10.1186\/s40813-022-00264-z (2022).","journal-title":"Porcine Health Manag."},{"key":"42377_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41575-018-0081-y","volume":"16","author":"H Gehart","year":"2019","unstructured":"Gehart, H. & Clevers, H. Tales from the crypt: New insights into intestinal stem cells. Nat. Rev. Gastroenterol. Hepatol. 16, 19\u201334. https:\/\/doi.org\/10.1038\/s41575-018-0081-y (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"42377_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jcmgh.2019.10.002","volume":"9","author":"J Wong","year":"2020","unstructured":"Wong, J. et al. RIPK1 mediates TNF-induced intestinal crypt apoptosis during chronic NF-kappaB activation. Cell Mol. Gastroenterol. Hepatol. 9, 295\u2013312. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.10.002 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"42377_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","volume":"55","author":"MS Madhur","year":"2010","unstructured":"Madhur, M. S. et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55, 500\u2013507. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.145094 (2010).","journal-title":"Hypertension"},{"key":"42377_CR27","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.112.199265","volume":"60","author":"L Marko","year":"2012","unstructured":"Marko, L. et al. Interferon-gamma signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension 60, 1430\u20131436. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.199265 (2012).","journal-title":"Hypertension"},{"key":"42377_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.137158","volume":"54","author":"SP Didion","year":"2009","unstructured":"Didion, S. P., Kinzenbaw, D. A., Schrader, L. I., Chu, Y. & Faraci, F. M. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 54, 619\u2013624. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.137158 (2009).","journal-title":"Hypertension"},{"key":"42377_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00737-2","author":"F Violi","year":"2022","unstructured":"Violi, F. et al. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat. Rev. Cardiol. https:\/\/doi.org\/10.1038\/s41569-022-00737-2 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"42377_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2014.12.001","volume":"122","author":"GF Bomfim","year":"2015","unstructured":"Bomfim, G. F. et al. Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats. Life Sci. 122, 1\u20137. https:\/\/doi.org\/10.1016\/j.lfs.2014.12.001 (2015).","journal-title":"Life Sci."},{"key":"42377_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12974-015-0242-7","volume":"12","author":"RB Dange","year":"2015","unstructured":"Dange, R. B., Agarwal, D., Teruyama, R. & Francis, J. Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension. J. Neuroinflamm. 12, 31. https:\/\/doi.org\/10.1186\/s12974-015-0242-7 (2015).","journal-title":"J. Neuroinflamm."},{"key":"42377_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature24628","volume":"551","author":"N Wilck","year":"2017","unstructured":"Wilck, N. et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature 551, 585\u2013589. https:\/\/doi.org\/10.1038\/nature24628 (2017).","journal-title":"Nature"},{"key":"42377_CR33","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1042\/CS20201017","volume":"135","author":"AA Elmarakby","year":"2021","unstructured":"Elmarakby, A. A. & Sullivan, J. C. Sex differences in hypertension: Lessons from spontaneously hypertensive rats (SHR). Clin. Sci. 135, 1791\u20131804. https:\/\/doi.org\/10.1042\/CS20201017 (2021).","journal-title":"Clin. Sci."},{"key":"42377_CR34","doi-asserted-by":"publisher","first-page":"H670","DOI":"10.1152\/ajpheart.00217.2022","volume":"323","author":"DK Sosnowski","year":"2022","unstructured":"Sosnowski, D. K. et al. Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function. Am. J. Physiol. Heart Circ. Physiol. 323, H670\u2013H687. https:\/\/doi.org\/10.1152\/ajpheart.00217.2022 (2022).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"42377_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5534\/wjmh.190009","volume":"38","author":"YS Kim","year":"2020","unstructured":"Kim, Y. S., Unno, T., Kim, B. Y. & Park, M. S. Sex differences in gut microbiota. World J. Mens Health 38, 48\u201360. https:\/\/doi.org\/10.5534\/wjmh.190009 (2020).","journal-title":"World J. Mens Health"},{"key":"42377_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mimet.2017.02.003","volume":"135","author":"JC Gomes-Neto","year":"2017","unstructured":"Gomes-Neto, J. C. et al. A real-time PCR assay for accurate quantification of the individual members of the Altered Schaedler Flora microbiota in gnotobiotic mice. J. Microbiol. Methods 135, 52\u201362. https:\/\/doi.org\/10.1016\/j.mimet.2017.02.003 (2017).","journal-title":"J. Microbiol. Methods"},{"key":"42377_CR37","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/jb.173.2.697-703.1991","volume":"173","author":"WG Weisburg","year":"1991","unstructured":"Weisburg, W. G., Barns, S. M., Pelletier, D. A. & Lane, D. J. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173, 697\u2013703. https:\/\/doi.org\/10.1128\/jb.173.2.697-703.1991 (1991).","journal-title":"J. Bacteriol."},{"key":"42377_CR38","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1099\/ijsem.0.001755","volume":"67","author":"SH Yoon","year":"2017","unstructured":"Yoon, S. H. et al. Introducing EzBioCloud: A taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies. Int. J. Syst. Evol. Microbiol 67, 1613\u20131617. https:\/\/doi.org\/10.1099\/ijsem.0.001755 (2017).","journal-title":"Int. J. Syst. Evol. Microbiol"},{"key":"42377_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1574-6968.2002.tb11468.x","volume":"217","author":"M Ventura","year":"2002","unstructured":"Ventura, M. & Zink, R. Specific identification and molecular typing analysis of Lactobacillus johnsonii by using PCR-based methods and pulsed-field gel electrophoresis. FEMS Microbiol. Lett. 217, 141\u2013154. https:\/\/doi.org\/10.1111\/j.1574-6968.2002.tb11468.x (2002).","journal-title":"FEMS Microbiol. Lett."},{"key":"42377_CR40","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.119.14636","volume":"76","author":"M Mukohda","year":"2020","unstructured":"Mukohda, M., Mizuno, R. & Ozaki, H. Increased blood pressure causes lymphatic endothelial dysfunction via oxidative stress in spontaneously hypertensive rats. Hypertension 76, 598\u2013606. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14636 (2020).","journal-title":"Hypertension"},{"key":"42377_CR41","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1172\/JCI123462","volume":"129","author":"M Mukohda","year":"2019","unstructured":"Mukohda, M. et al. RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity. J. Clin. Investig. 129, 2318\u20132332. https:\/\/doi.org\/10.1172\/JCI123462 (2019).","journal-title":"J. Clin. Investig."},{"key":"42377_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17071171","author":"W Liu","year":"2016","unstructured":"Liu, W. et al. Developments in methods for measuring the intestinal absorption of nanoparticle-bound drugs. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms17071171 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"42377_CR43","doi-asserted-by":"publisher","DOI":"10.3791\/53250","author":"SW Mateer","year":"2016","unstructured":"Mateer, S. W. et al. Ex vivo intestinal sacs to assess mucosal permeability in models of gastrointestinal disease. J. Vis. Exp. https:\/\/doi.org\/10.3791\/53250 (2016).","journal-title":"J. Vis. Exp."},{"key":"42377_CR44","doi-asserted-by":"publisher","first-page":"H1118","DOI":"10.1152\/ajpheart.00496.2022","volume":"323","author":"M Mukohda","year":"2022","unstructured":"Mukohda, M., Mizuno, R., Saito, F., Matsui, T. & Ozaki, H. Hypertension is linked to enhanced lymphatic contractile response via RGS16\/RhoA\/ROCK pathway. Am. J. Physiol. Heart Circ. Physiol. 323, H1118\u2013H1129. https:\/\/doi.org\/10.1152\/ajpheart.00496.2022 (2022).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"42377_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2288-11-40","volume":"11","author":"A Vellinga","year":"2011","unstructured":"Vellinga, A., Cormican, M., Hanahoe, B., Bennett, K. & Murphy, A. W. Opt-out as an acceptable method of obtaining consent in medical research: A short report. BMC Med. Res. Methodol. 11, 40. https:\/\/doi.org\/10.1186\/1471-2288-11-40 (2011).","journal-title":"BMC Med. Res. Methodol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42377-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42377-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42377-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T09:16:16Z","timestamp":1700385376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42377-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42377"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42377-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15197"}}